MONASH researchers are trialling
beta-blockers as a potential way to
slow the spread of breast cancer.
Anaesthetist Dr Jonathan Hiller
is leading the clinical trials at the
Peter MacCallum Cancer Centre.
It builds on earlier findings
from the Monash Institute of
Pharmaceutical Science which
found chronic stress acts as a
fertiliser for tumour cells.
Hiller’s hypothesis is that betablockers,
which reduce blood
pressure by blocking the effect of
stress hormones, could potentially
help prevent the effects of acute
stress encountered in cancer
diagnosis and treatment.The above article was sent to subscribers in Pharmacy Daily's issue from 22 Feb 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 22 Feb 16
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.